1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Celltrion, Inc.
  6. News
  7. Summary
    A068270   KR7068270008

CELLTRION, INC.

(A068270)
  Report
End-of-day quote Korea Stock Exchange  -  2022-08-09
211500.00 KRW    0.00%
08/09Celltrion Files IND With FDA For Adalimumab Biosimilar
AQ
08/07Celltrion's Net Income Jumps 41.2% in June Quarter
MT
08/05S.Korean shares post third straight weekly gain
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Celltrion, Inc. authorizes a Buyback Plan.

05/18/2022 EDT

The Board of Directors of Celltrion, Inc. has authorized a buyback plan on May 18, 2022.


© S&P Capital IQ 2022
All news about CELLTRION, INC.
08/09Celltrion Files IND With FDA For Adalimumab Biosimilar
AQ
08/07Celltrion's Net Income Jumps 41.2% in June Quarter
MT
08/05S.Korean shares post third straight weekly gain
RE
08/05CELLTRION : 2Q 2022 Earnings Release_Celltrion Inc.
PU
07/26Tranche Update on Celltrion, Inc.'s Equity Buyback Plan announced on May 18, 2022.
CI
07/26Tranche Update on Celltrion, Inc.'s Equity Buyback Plan announced on May 18, 2022.
CI
07/22Celltrion, Inc.'s Equity Buyback announced on May 18, 2022, has closed with 500,000 sha..
CI
07/19Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle Eas..
AQ
06/26Celltrion Wins Sales Approval Recommendation For Its CT-P16 From European Medicines Age..
RE
06/06Celltrion Eyes to Boost Market Share in Europe of Rheumatoid Arthritis Medication to 50..
MT
More news
Analyst Recommendations on CELLTRION, INC.
More recommendations
Financials
Sales 2022 2 256 B 1,74 B 1,74 B
Net income 2022 601 B 0,46 B 0,46 B
Net cash 2022 681 B 0,52 B 0,52 B
P/E ratio 2022 49,3x
Yield 2022 0,19%
Capitalization 29 135 B 22 444 M 22 444 M
EV / Sales 2022 12,6x
EV / Sales 2023 11,4x
Nbr of Employees 2 034
Free-Float 75,0%
Chart CELLTRION, INC.
Duration : Period :
Celltrion, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CELLTRION, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 211 500,00 KRW
Average target price 218 060,78 KRW
Spread / Average Target 3,10%
EPS Revisions
Managers and Directors
Wu-Sung Ki Chief Executive Officer & Director
Ho-Seop Lee Finance Director
Jung-Jin Seo Chairman
Sung-Han Lee Head-Legal & Compliance Support
Dong-Il Kim Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CELLTRION, INC.6.82%22 444
MODERNA, INC.-31.38%68 174
LONZA GROUP AG-26.76%44 940
IQVIA HOLDINGS INC.-15.05%44 704
SEAGEN INC.13.62%32 396
ALNYLAM PHARMACEUTICALS, INC.36.81%27 846